Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy

The prognostic value of plasma Epstein-Barr virus (EBV) DNA remains unknown in nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiation therapy (IMRT). We retrospectively reviewed medical records of 584 newly diagnosed patients with nonmetastatic and biopsy-proven NPC treated using...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hao, Guo, Rui, Chen, Lei, Zhang, Yuan, Li, Wen-Fei, Mao, Yan-Ping, Sun, Ying, Zhang, Fan, Liu, Li-Zhi, Lin, Ai-Hua, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770420/
https://www.ncbi.nlm.nih.gov/pubmed/26924234
http://dx.doi.org/10.1038/srep22000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770420/
https://www.ncbi.nlm.nih.gov/pubmed/26924234
http://dx.doi.org/10.1038/srep22000

Ejemplares similares